| |
Name of Drug |
|
Dosage Forms and Strengths |
2.2 |
Narcotic Antagonists (Drugs for Treatment of Opioid Dependence) |
| |
Methadone |
- |
Tablet, 5 mg |
6.6 |
Antimalarial Drugs |
|
|
| |
Halofantrine |
- |
Tablet, (hydrochloride) 250 mg Syrup, 100 mg/5 mL |
6.8 |
Antibacterial Drugs |
|
|
| |
Azithromycin |
- |
Capsule, 250 mg |
| |
|
- |
Capsule, Tablet, 200 mg |
| |
Ofloxacin |
- |
Injection, IV, 100 mg/50 mL, 200 mg/100 mL |
6.11 |
Systemic Antifungal Drugs |
|
|
| |
Terbinafine |
- |
Tablet, (hydrochloride), 250 mg |
6.13 |
ARVs Supplementary List |
|
|
| |
Stavudine plus Lamivudine plus Nevirapine |
- |
FIRST LINE |
| |
Didanosine |
- |
SECOND LINE |
| |
|
|
Tablet, 100 mg, 150 mg, 200 mg |
| |
Ritonavir plus Lopinavir (RTV-LPV) |
- |
SECOND LINE - ALTERNATIVE (OR THIRD LINE)
Capsule, Ritonavir, 33.3 mg plus Lopinavir 133.3 mg |
| |
|
- |
Oral solution, Ritonavir, 100 mg plus Lopinavir, 400 mg/5 mL |
| |
Efavirenz |
- |
Capsule, 50 mg, 100 mg |
8. |
ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS |
|
|
| |
Stilboestrol |
- |
Tablet, 0.5 mg, 1 mg, 5 mg, 25 mg |
11.1 |
Antianaemia Drugs |
|
|
| |
Iron dextran |
- |
Injection equivalent to 50 mg iron/mL, in 2 mL ampoule |
12.4 |
Medicines Used in Heart failure |
|
|
| |
Dopamine |
- |
Injection (hydrochloride), 40 mg/mL in 5 mL vial |
14.2 |
Anti-inflammatory and Antipruritic Drugs |
|
|
| |
Clobetasol |
- |
Cream, Ointment, (propionate), 0.05% |
| |
Fluocinolone |
- |
Cream, Ointment (acetonide), 0.025% |
14.8 |
Sunscreen Agents |
|
|
| |
Aminobenzoic acid |
- |
Lotion, 5% |
| |
|
- |
Cream, 5% |
| |
|
- |
Paste, 5% |
| |
Titanium dioxide |
- |
Cream, 20 -25% |
| |
|
- |
Paste, 20 - 25% |
15.1 |
Gastric Function |
|
|
| |
Corticotrophin |
- |
Injection (tetracosactide), 250 ug (acetate)/mL |
| |
|
- |
Injection (aqueous suspension), tetracosactide 1 mg (acetate)/mL with Zinc phosphate complex |
| |
Histamine phosphate |
- |
Injection, 2.75 mg/mL in ampoule |
| |
Pengrastrin |
- |
Injection, 0.25 mg/mL ampoule |
15.2 |
Myasthenia Gravis |
|
|
| |
Edrophonium |
- |
Injection, (chloride), 10 mg/mL |
15.6 |
Diagnostic Agents For Endocrine Disorders |
|
|
| |
Luteinizing Hormone - Releasing Hormone (LH-RH) |
- |
Injection, 0.1 mg/mL in 1 mL ampoule |
| |
Metyrapone |
- |
Capsule, Tablet, 250 mg |
| |
Thyrotrophin Hormone (TRH) |
- |
Injection, 0.2 mg/mL |
19.1 |
Corticosteroids and Synthetic Substitutes |
|
|
| |
Fludrocortisone |
- |
Tablet, 0.1 mg |
| |
Methylprednisolone |
- |
Injection, (acetate), 40 mg/mL in 1 mL, 2 mL & 5 mL vials |
| |
Triamcinolone |
- |
Injection, (acetonide), 10 mg/mL, 40 mg/mL, IM, IA, ID |
19.2 |
Oestrogens/Androgens |
|
|
| |
Mesterolone |
- |
Tablet, 25 mg |
| |
Testosterone |
- |
Injection, 200 mg in 1 mL |
| |
Stilboestrol |
- |
Tablet, 0.5 mg, 1 mg, 5 mg, 25 mg |
19.6 |
Drugs Acting on Pituitary Ovarian Axis |
|
|
| |
Chorionic Gonadotrophin |
- |
Injection powder, 500 Units, 1000 Units, in ampoule |
| |
Danazol |
- |
Capsules, 100 mg, 200 mg |
| |
Epimestrol |
- |
Tablet, 5 mg |
| |
Follicle-Stimulating Hormone (FSH) plus Luteinizing Hormone (LH) |
- |
Injection powder for reconstitution, human FSH, 75 Units plus human LH, 75 Units |
19.8 |
Antidiuretic Hormones |
|
|
| |
Desmopressin |
- |
Injection, 4 micrograms/mL |
| |
|
- |
Nasal Spray, 10 micrograms/metered spray |
| |
|
- |
Intr-nasal solution, 100 micrograms/mL |
| |
Vasopressin |
- |
Injection, 20 units/mL in 1 mL ampoule |
25.3 |
Antipsychotics (Major Tranquillizers) |
|
|
| |
Fluoxetine |
- |
Capsule, 20 mg |
| |
|
- |
Oral solution, 20 mg/5 mL |
| |
Lithium carbonate |
- |
Capsule, Tablet, 300 mg |
| |
Pimozide |
- |
Tablet, 4 mg, 10 mg |
